Rare diseases
Investigational molecules
Locations
Back to France990 clinical trials in STRASBOURG, Alsace, France across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FranceStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
FranceStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
FrancePhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
FranceA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
FranceA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
FranceA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
FranceA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
FranceA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
FranceA Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity
FranceA study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer's disease
FranceStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
FranceThe busiest research cities in the country
What the registry says about research in the country
Advanced studies focusing on head and neck cancers, bladder cancer, and multiple myeloma. Novel therapeutic approaches combining immunotherapy with established treatments are being evaluated for improved patient outcomes.
Innovative combination therapies are being tested to enhance treatment efficacy while maintaining patient safety.
Comprehensive research into multiple sclerosis, essential tremor, and ADHD. Studies are evaluating both new and existing medications for improved symptom management and disease control.
Advanced neuroimaging techniques are being utilized to understand treatment effects on brain circuits.
Investigating new treatments for Crohn's disease, Sjögren's Syndrome, and Myasthenia Gravis. Research focuses on innovative therapeutic approaches including microbiota transplantation and targeted immunotherapies.
These trials aim to improve disease management and patient quality of life through targeted interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
